Answers are grounded in this paper and cite their sources.
Novel fluorometric tool detects vismodegib effectively, suggesting improved drug monitoring in patients.
Accurate determination of vismodegib (VISMO), a Hedgehog pathway inhibitor approved for the management of basal cell carcinoma and other malignancies, is essential for pharmacokinetic assessment, dose optimization, and therapeutic drug monitoring.
No takes yet. Share an insight, caveat, or question.
Alaseem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: